Meteora Capital’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-377,372
Closed -$3.78M 551
2022
Q3
$3.78M Buy
377,372
+228,983
+154% +$2.28M 0.96% 20
2022
Q2
$1.47M Buy
148,389
+75,805
+104% +$749K 0.28% 76
2022
Q1
$716K Buy
+72,584
New +$713K 0.26% 89

Meteora Capital's LUXA Position: Q4 2022 in Review

Meteora Capital sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 377,372 shares — an estimated $3.78M sold.

Meteora Capital first reported a position in LUXA in Q1 2022 and held it in 3 quarters. The position peaked at $3.78M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

  • Meteora Capital reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Meteora Capital sold 377,372 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $3.78M.
  • Meteora Capital first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Meteora Capital's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $3.78M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Meteora Capital's 13F filing for Q4 2022, filed 14 Feb 2023.